This Pharma Giant is Prioritizing Shareholder Dividends
It currently yields around 4% and is a buy under $38 a share.
Read MoreAuthor: Tony Daltorio, Investors Alley
The One Stock Turning AI Into Huge Profits (take advantage of the current weakness)
It’s doubled its revenue in the past year and is expected to keep growing at a healthy rate.
Read MoreThis Stock is Positioned Well for the Long-Term — Buy It Below $125
It’s a great time to be a company that refines oil…
Read MoreThis Stock Yields 9.1% and is a Buy on Any Market Weakness
Its target “buy” price is in the $13.00-$13.75 range.
Read MoreHigh-Yield Opportunity: You Need to Be Buying BDCs Right Now
Here are a few to consider, with yields in excess of 9%.
Read More
